Managing AST levels in cancer patients involves addressing the underlying cause. For instance:
If elevated AST levels are due to chemotherapy, adjusting the dose or switching to a less hepatotoxic agent may be necessary. If liver metastasis is the cause, specific treatments targeting the liver metastases, such as localized therapies or systemic treatments, may be considered. Supportive care, including medications to protect the liver and dietary adjustments, can also help manage AST levels.
